ArticlePlants (Basel, Switzerland)2025
Resistance Spectrum Analysis and Breeding Utilization of Rice Blast Resistance Gene
Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Genetic identification of Pid3-1 and its regulatory role in promoting blast resistance in rice.G3 (Bethesda, Md.) · 2026Article
- Correction: Jin et al. Resistance Spectrum Analysis and Breeding Utilization of Rice Blast Resistance GenePlants (Basel, Switzerland) · 2025Article
- The Molecular Breeding of Different EcotypePlants (Basel, Switzerland) · 2025Article
- Crop Functional Genomics and Biological Breeding.Plants (Basel, Switzerland) · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
Rice blast is one of the most important diseases of rice, causing significant economic losses to agricultural production. A new gene,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.